Search Results for "drugs for parasitic infections"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for drugs for parasitic infections. Results 21 to 24 of 24 total matches.
Nifurtimox (Lampit) for Chagas Disease (online only)
The Medical Letter on Drugs and Therapeutics • Jul 22, 2024 (Issue 1707)
Nifurtimox (Lampit) for Chagas Disease
The FDA has approved the nitrofuran antiprotozoal drug ...
The FDA has approved the nitrofuran antiprotozoal drug
nifurtimox (Lampit – Bayer) for treatment of Chagas
disease (American trypanosomiasis) in children who
weigh ≥2.5 kg. Nifurtimox was previously available in
the US only through a CDC-sponsored Investigational
New Drug (IND) program.
Med Lett Drugs Ther. 2024 Jul 22;66(1707):e123-4 doi:10.58347/tml.2024.1707h | Show Introduction Hide Introduction
Rifamycin (Aemcolo) for Treatment of Travelers' Diarrhea
The Medical Letter on Drugs and Therapeutics • Mar 11, 2019 (Issue 1567)
. coli. Infections with other bacteria such
as Shigella spp., Salmonella spp., and Campylobacter
jejuni ...
The FDA has approved rifamycin (Aemcolo – Cosmo/
Aries), a minimally absorbed oral antibiotic, for
treatment of adults with travelers' diarrhea (TD)
caused by noninvasive strains of Escherichia coli. It
is not recommended for treatment of diarrhea that is
complicated by fever and/or bloody stools. Topical
and injectable formulations of rifamycin have been
used in Europe for other indications for many years.
Rifaximin (Xifaxan) for Travelers' Diarrhea
The Medical Letter on Drugs and Therapeutics • Sep 13, 2004 (Issue 1191)
®
On Drugs and Therapeutics
Published by The Medical Letter, Inc. 1000 Main Street, New Rochelle, NY ...
Rifaximin (Xifaxan - Salix), a non-absorbed oral antibiotic derived from rifampin (Rifadin, and others), has been approved by the FDA for treatment of travelers' diarrhea caused by noninvasive strains of Escherichia coli in patients 12 years of age or older. It has been available in Europe since 1987.
Table: Treatments Considered for COVID-19 (Archived) (online only)
The Medical Letter on Drugs and Therapeutics • Apr 06, 2020 (Issue 1595)
-2 infection. CMAJ 2020 April 8 (epub).
6. DM Roden et al. Drug interactions on QTc in exploratory ...
View the Table: Treatments Considered for COVID-19